Learn how outsourcing this key aspect of bringing product to market can benefit your organization and overall supply chain optimization.

Determine your plan now for serialization readiness to put the worries of DSCSA costs and timelines behind you and patient safety back where it belongs — at the forefront.

The FDA’s intent to not enforce the requirements of the Drug Supply Chain Security Act until November 2018 offered an additional year meet compliance. The deadline for that grace period is now!

Learn what indicates whether a service provider has the capabilities desired by a drug sponsor to fulfill a company’s long-term goals and is committed to their success.

From fully developed large-scale manufacturing and packaging to a single development batch, a contract services organization must be prepared to handle multiple compounds in the same facility.

As with the pharma industry, packagers are challenged to grow through innovation, by providing formats which satisfy pharma's expectation of enhanced drug integrity, safety, and stability while delivering the convenience demanded by today's consumer.

An effective quality agreement communicates the responsibilities of each party in a clear, concise manner, allowing the reader to quickly and accurately determine to whom a specific responsibility is assigned. 

Quality metrics have been widely used in the pharma industry to monitor quality systems, operational processes, and to promote continuous improvement initiatives in drug manufacturing. 

A contract packaging partner should function as an extension of the pharma’s organization, so careful consideration should be devoted to initiating this relationship. 

Determining a drug candidate’s probability of commercial success is a significant phase in the drug development process. There is no room for error.

Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations. Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

Understanding the FDA audit process, preparing for it and being aware of regulations will help to restore a sense of control and help to ensure the best outcome.

Emerging countries offer a nearly untapped opportunity. Despite the opportunities, these markets also hold unique challenges. Blister packaging effectively addresses these challenges.

Learn why the trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. 

Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

This regulation from the FDA outlined serialization and traceability requirements spread over the course of 10 years with preparation for each phase accumulating into a potentially high overall price tag.

Ensure you understand the expectations of regulators and what you can do to facilitate successful paper-based inspections in lieu of those performed on-site.

Without proper handling and packaging, the efficacy of probiotics can be compromised at any point of the packaging, storage, and transportation process, impacting shelf life and effectiveness.

A contact packaging leader outfits its new facility with a new stick packaging line, giving pharmaceutical and nutraceutical companies another way to ease product use. By Ropack, Inc.

Ropack provides contract bottle filling of HDPE, PET, glass and flip-top vial bottles for tablets, capsules, soft/liquid gels and powders. With a bottling capacity of 20 million and 12 million for flip-top vials, Ropack brings the efficiency of five bottling lines with quick changeovers, on-line validated fill accuracy and the flexibility to accommodate small lots to commercial runs.

Ropack provides encapsulation services of solid oral dosage to the pharmaceutical, natural health product and food supplement industries in cGMP, FDA and Health Canada regulated production suites.

Ropack, Your Trusted Packaging Partner provides a number of pouch and sachet filling services for powder, solid, liquid, and other dosage types. Pouch and Sachet filling under nitrogen and pouch filling in a controlled-humidity environment are also available.

Ropack provides a number of blister packaging services and can produce blister packaging in several different forms, including regular thermo-form, cold-formed, and heat-sealed blister cards.

Ropack offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages, tablets, powder, and encapsulation into blisters, pouches, bottles, carded blisters and syringe assembly. Our facilities are cGMP compliant and FDA certified. Ropack is competitive, flexible and agile; supporting clinical trials, short run start-ups, commercial production and warehousing and distribution services for over 100 U.S., Canadian and European pharmaceutical and nutraceutical customers.

Ropack, Your Trusted Packaging Partner provides Stick-Pack Packaging. Stick-packs offer consumers the convenience and flexibility their active lives demand. An ideal format for pediatric and geriatric formulations. Stick-packs offer consumers the convenience and flexibility their active lives demand. An ideal format for pediatric and geriatric formulations.

Ropack, Your trusted packaging partner produces exact filling of HDPE, PET and Glass bottles. Bottles are sealed with induction seals, permaseals, and child-resistant or senior-friendly caps.

Ropack, Your Trusted Packaging Partner provides in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security.

Ropack's in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security. When pharmas and CROs send bulk product, Ropack purchases components in country and eliminates the governmental red tape and associated cost of shipping from out of country.

Contract packaging for pharmaceutical and consumer health-care is Ropack's core service. Global customers rely on our exacting production environments — 32 Class 100,000 Clean Rooms, including a dedicated facility ensuring low RH and controlled temperature. With four production facilities totaling nearly 250,000 square feet, Ropack has ample capacity, state-of-the-industry technology and the flexibility to provide stability and commercial production in short and long runs.